Clinical uses of naltrexone: A review of the evidence.

Vania Modesto‐Lowe, Jeffrey Van Kirk·2002·Experimental and Clinical Psychopharmacology

Abstract

The implication of the opioidergic system in the pathogenesis of various substance use disorders has led to renewed interest in expanding the clinical uses of naltrexone, an opioid antagonist. This article examines the evidence for the efficacy of naltrexone in a variety of substance use and psychiatric disorders. Naltrexone can be an effective treatment for alcohol and opioid dependence if issues of compliance are adequately addressed. Thus far, no definitive role has been found for naltrexone in the treatment of other psychiatric disorders. Further research needs to be done in self-injurious behavior, gambling, cocaine, and nicotine dependence.

Cites (6)

  1. Naltrexone in the Treatment of Alcohol Dependence
    Volpicelli, Joseph R. · 1992 · Archives of General Psychiatry
  2. Untitled work
    Pomerlau · 1984 · 10.1016/0149-7634(84)90007-1
  3. Naloxone reduces cigarette smoking
    Karras, A., Kane, J.M. · 1980 · Life Sciences
  4. Naltrexone and relapse prevention treatment for cocaine-dependent patients
    Schmitz, Joy M, Stotts, Angela L, Rhoades, Howard M, Grabowski, John · 2001 · Addictive Behaviors
  5. Brief report: A double-blind study of naltrexone in infantile autism
    Leboyer, Marion, Bouvard, Manuel P., Launay, Jean-Marie, Tabuteau, Fran�ois, Waller, D�lphine, Dugas, Michel, Kerdelhue, Bernard, Lensing, Patrick, Panksepp, Jaak · 1992 · Journal of Autism and Developmental Disorders
  6. Naltrexone and Self-Injurious Behavior: A Retrospective Population Study
    Casner, John A., Weinheimer, Bruce, Gualtieri, C. Thomas · 1996 · Journal of Clinical Psychopharmacology

Show all 6 references

Cited by (5)

  1. Pathological gambling: Etiology, comorbidity, and treatment.
    Petry, Nancy M. · 2005
  2. The Status of Disulfiram: A Half of a Century Later
    Suh, Jesse J., Pettinati, Helen M., Kampman, Kyle M., O'Brien, Charles P. · 2006 · Journal of Clinical Psychopharmacology
  3. Why gamblers fail to win: A review of cognitive and neuroimaging findings in pathological gambling
    van Holst, Ruth J., van den Brink, Wim, Veltman, Dick J., Goudriaan, Anna E. · 2010 · Neuroscience & Biobehavioral Reviews
  4. Conceptualizing the neurobiology of non-suicidal self-injury from the perspective of the Research Domain Criteria Project
    Westlund Schreiner, Melinda, Klimes-Dougan, Bonnie, Begnel, Erin D., Cullen, Kathryn R. · 2015 · Neuroscience & Biobehavioral Reviews
  5. Naltrexone for severe self-harm behavior: a case report
    Agarwal, Lauren J., Berger, Christopher Eric, Gill, Leia · 2011 · American Journal of Psychiatry

See all 74

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical uses of naltrexone: A review of the evidence. https://app.cochat.ai/papers/10.1037//1064-1297.10.3.213
The paper
Modesto‐Lowe, V., & Kirk, J. V. (2002). Clinical uses of naltrexone: A review of the evidence. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037//1064-1297.10.3.213

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.